Meta-Analysis of Creatine for Neuroprotection Against Parkinson's Disease.
Attia, Ahmed H, Gadelkarim M, Morsi M, Awad K, Elnenny M, Ghanem E, El-Jaafary S, Negida A.
Attia, et al. Among authors: ghanem e.
CNS Neurol Disord Drug Targets. 2017;16(2):169-175. doi: 10.2174/1871527315666161104161855.
CNS Neurol Disord Drug Targets. 2017.
PMID: 27823574
Review.